Share
USER HOTLINE: call us at +49 30 65499 145 | Not all products are available in the USA.
January 27, 2025
Prof. Daniel Wendt on the results of the second interim STAR Registry analysis

Prof Dr Daniel Wendt on the results of the second interim STAR Registry analysis: “Hemoadsorption appears to be a feasible, safe and potentially effective solution for reducing perioperative bleeding in patients on oral anticoagulants”

Welcome to our Blog!

I want to welcome you to our official CytoSorbents Blog “Let’s talk…” and personally invite you to discuss and exchange opinions via this platform.

 

CytoSorbents’ adsorption technology represents a new approach to blood purification. As these new tools have to be used adequately to help patients in different situations, there is a need for continuous development and knowledge generation. Discussions, explanations, brainstorming and interaction in general can catalyze and accelerate this process. We will come up with interesting topics, new publications – which may even be controversial –, hypotheses, and food for thoughts to inspire and stimulate dialogue.

 

So, I want to invite all users of our products, interested healthcare professionals, researchers, thinkers, supporters, and especially critics to actively discuss and share your opinion on relevant topics to progress with the development of patient-centric precision therapy schemes.

 

I thank you in anticipation.

 

Christian

Picture of Dr. Christian Steiner
Christian Steiner, MD Executive Vice President of Sales and Marketing

All our Blog Posts

January 27, 2025
Prof. Daniel Wendt on the results of the second interim STAR Registry analysis

Prof Dr Daniel Wendt on the results of the second interim STAR Registry analysis: “Hemoadsorption appears to be a feasible, safe and potentially effective solution for reducing perioperative bleeding in patients on oral anticoagulants”

July 08, 2024
Achieved: 1,000 entries in CytoSorb Literature Database

The CytoSorb Literature Database has just surpassed 1,000 entries – One thousand peer reviewed publications, poster presentations from national and international conferences and case reports from many different hospitals worldwide. As such, CytoSorb stands as the most researched and published hemoadsorption therapy of its kind.

May 27, 2024
STAR Registry Unveils Promising Insights

Prof Dr Daniel Wendt on: Intraoperative hemoadsorption for antithrombotic drug removal during cardiac surgery: Initial report of the International Safe and Timely Antithrombotic Removal (STAR) Registry.

May 21, 2024
CytoSorb’s important role in severe rhabdomyolysis requiring continuous veno-venous haemodialysis

Dr Volker Humbert on: Rapid and effective elimination of myoglobin with CytoSorb® hemoadsorber in patients with severe rhabdomyolysis.

May 21, 2024
Unveiling the Impact of CytoSorb Therapy on Fluid Balance in Septic Shock Patients

Unveiling the Impact of CytoSorb Therapy on Fluid Balance in Septic Shock Patients Dr Jörg Scheier on: “Impact of CytoSorb Hemoadsorption Therapy on Fluid Balance in Patients with Septic Shock” Kogelmann K, Hübner T, Drüner M, Jarczak D. Journal of Clinical Medicine

April 11, 2024
Improving Heart Transplant Outcomes: The Role of CytoSorb

Get to know more about Nemeth et al. reporting on the results of a single site study of 60 patients undergoing heart transplantation, randomised to receive CytoSorb or standard treatment.

CytoSorbents

Voices around the world

world map
Critical Care
Dr. Vanja Persic
Slovenia, Ljubljana

Use of CytoSorb in shocked SIRS patients was associated with rapid IL-6 decrease and hemodynamic improvement, with improved observed vs predicted survival.

Cardiovascular
Dr. Haider Ghaidan
Sweden, Lund

CytoSorb restored lung function and reduced PGD in lung transplantation. We suggest this treatment will increase tolerability of donor lungs in recipients.

Critical Care
Dr. Gabriella Bottari
Italy, Rome

Hemoperfusion with CytoSorb in combination with continuous kidney renal therapy is a valuable therapeutic option in sepsis-associated acute kidney injury.